189 related articles for article (PubMed ID: 20925952)
21. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.
Gallus GN; Dotti MT; Federico A
Neurol Sci; 2006 Jun; 27(2):143-9. PubMed ID: 16816916
[TBL] [Abstract][Full Text] [Related]
22. Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families.
Chen C; Zhang Y; Wu H; Sun YM; Cai YH; Wu JJ; Wang J; Gong LY; Ding ZT
Metab Brain Dis; 2017 Oct; 32(5):1609-1618. PubMed ID: 28623566
[TBL] [Abstract][Full Text] [Related]
23. Four novel CYP27A1 mutations in seven Italian patients with CTX.
Gallus GN; Dotti MT; Mignarri A; Rufa A; Da Pozzo P; Cardaioli E; Federico A
Eur J Neurol; 2010 Oct; 17(10):1259-62. PubMed ID: 20402754
[TBL] [Abstract][Full Text] [Related]
24. Cerebrotendinous xanthomatosis with a compound heterozygote mutation and severe polyneuropathy.
Wang Z; Yuan Y; Zhang W; Zhang Y; Feng L
Neuropathology; 2007 Feb; 27(1):62-6. PubMed ID: 17319284
[TBL] [Abstract][Full Text] [Related]
25. Two new mutations in the sterol 27-hydroxylase gene in two families lead to cerebrotendinous xanthomatosis.
Verrips A; Steenbergen-Spanjers GC; Luyten JA; van den Heuvel LP; Keyser A; Gabreëls FJ; Wevers RA
Hum Genet; 1996 Dec; 98(6):735-7. PubMed ID: 8931710
[TBL] [Abstract][Full Text] [Related]
26. A case of cerebrotendinous xanthomatosis with brain and spinal involvement without tendon xanthomas: Identification of a novel mutation of the CYP27A1 gene.
Stenos C; Kalafatakis K; Constantoulakis P; Zekiou K; Margoni A; Kardara P; Terentiou A; Stouraitis G; Nikolaou G
J Clin Lipidol; 2022; 16(3):281-285. PubMed ID: 35428606
[TBL] [Abstract][Full Text] [Related]
27. Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes.
Appadurai V; DeBarber A; Chiang PW; Patel SB; Steiner RD; Tyler C; Bonnen PE
Mol Genet Metab; 2015 Dec; 116(4):298-304. PubMed ID: 26643207
[TBL] [Abstract][Full Text] [Related]
28. Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease.
Keren Z; Falik-Zaccai TC
Pediatr Endocrinol Rev; 2009 Sep; 7(1):6-11. PubMed ID: 19696711
[TBL] [Abstract][Full Text] [Related]
29. Cerebrotendinous Xanthomatosis patients with late diagnosed in single orthopedic clinic: two novel variants in the CYP27A1 gene.
Köroğlu M; Karakaplan M; Gündüz E; Kesriklioğlu B; Ergen E; Aslantürk O; Özdemir ZM
Orphanet J Rare Dis; 2024 Feb; 19(1):53. PubMed ID: 38336741
[TBL] [Abstract][Full Text] [Related]
30. Cerebrotendinous xanthomatosis.
Björkhem I
Curr Opin Lipidol; 2013 Aug; 24(4):283-7. PubMed ID: 23759795
[TBL] [Abstract][Full Text] [Related]
31. A novel mutation in the CYP27A1 gene in a family with cerebrotendinous xanthomatosis.
Tang Y; Liu Y; Li D; Guo D; Xing Y
Int J Neurosci; 2020 Oct; 130(10):972-975. PubMed ID: 31914338
[TBL] [Abstract][Full Text] [Related]
32. A Rare Case of Cerebrotendinous Xanthomatosis Associated With a Mutation on COG8 Gene.
Ghoshouni H; Sarmadian R; Irilouzadian R; Biglari HN; Gilani A
J Investig Med High Impact Case Rep; 2023; 11():23247096231168109. PubMed ID: 37083278
[TBL] [Abstract][Full Text] [Related]
33. Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees.
Lee MH; Hazard S; Carpten JD; Yi S; Cohen J; Gerhardt GT; Salen G; Patel SB
J Lipid Res; 2001 Feb; 42(2):159-69. PubMed ID: 11181744
[TBL] [Abstract][Full Text] [Related]
34. A novel frameshift mutation in the sterol 27-hydroxylase gene in an Egyptian family with cerebrotendinous xanthomatosis without cataract.
Abdel-Hamid MS; Issa MY; Otaify GA; Zaki MS
Metab Brain Dis; 2017 Apr; 32(2):311-315. PubMed ID: 28229379
[TBL] [Abstract][Full Text] [Related]
35. [Pathophysiology of cerebrotendinous xanthomatosis].
Koyama S; Kato T
Rinsho Shinkeigaku; 2016 Dec; 56(12):821-826. PubMed ID: 27840382
[TBL] [Abstract][Full Text] [Related]
36. Clinical and genetic characteristics of Chinese patients with cerebrotendinous xanthomatosis.
Tao QQ; Zhang Y; Lin HX; Dong HL; Ni W; Wu ZY
Orphanet J Rare Dis; 2019 Dec; 14(1):282. PubMed ID: 31796091
[TBL] [Abstract][Full Text] [Related]
37. Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports.
Di Taranto MD; Gelzo M; Giacobbe C; Gentile M; Marotta G; Savastano S; Dello Russo A; Fortunato G; Corso G
Metab Brain Dis; 2016 Oct; 31(5):1185-8. PubMed ID: 27225395
[TBL] [Abstract][Full Text] [Related]
38. Genetic analysis of a Japanese cerebrotendinous xanthomatosis family: identification of a novel mutation in the adrenodoxin binding region of the CYP 27 gene.
Chen W; Kubota S; Nishimura Y; Nozaki S; Yamashita S; Nakagawa T; Kameda-Takemura K; Menju M; Matsuzawa Y; Björkhem I; Eggertsen G; Seyama Y
Biochim Biophys Acta; 1996 Nov; 1317(2):119-26. PubMed ID: 8950197
[TBL] [Abstract][Full Text] [Related]
39. Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP 27) leads to alternative pre-mRNA splicing by activating a cryptic 5' splice site at the mutant codon in cerebrotendinous xanthomatosis patients.
Chen W; Kubota S; Teramoto T; Nishimura Y; Yonemoto K; Seyama Y
Biochemistry; 1998 Mar; 37(13):4420-8. PubMed ID: 9521761
[TBL] [Abstract][Full Text] [Related]
40. Sudden death due to cerebrotendinous xanthomatosis confirmed by mutation analysis.
Sperhake JP; Matschke J; Orth U; Gal A; Püschel K
Int J Legal Med; 2000; 113(2):110-3. PubMed ID: 10741487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
